Kiniksa Pharmaceuticals International, plc (KNSA) Total liabilities 2021–2025
Kiniksa Pharmaceuticals International, plc (KNSA) total liabilities at each fiscal year-end, per SEC filings.
$196.0MFY2025 · since FY2021: $47.8M → $196.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $196.0M | +37.9% |
| FY2024 | $142.1M | +62.5% |
| FY2023 | $87.5M | +37.7% |
| FY2022 | $63.5M | +33.0% |
| FY2021 | $47.8M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice